Expertise of providers, legitimacy of therapies examined
Aug. 1, 2019, Tempe, Arizona — Unproven and unregulated stem cell therapies for treatments for conditions ranging from Parkinson’s disease to multiple sclerosis to macular degeneration are putting patients at risk in a market that has grown rapidly in recent years.Continue reading
Curtis Thorne, PhD, and UA doctoral student Carly Cabel validated findings from a 2018 collaborative study that identified a possible new therapeutic target for colon cancer – after a Harvard lab challenged the initial results.Continue reading
Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares.
Castle Biosciences is a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions.
The company is headquartered in Friendswood, Texas and has Laboratory/Clinical Operations in Phoenix, Arizona.
Arizona State University announced today that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or their precursors. The DARPA award, worth up to $38.8 million over four years in phases and options, will build on the university’s growing capabilities in developing molecular diagnostics for applications in defense and human health.Continue reading
TGen and Tufts University novel findings for this deadly bone cancer could lead to better treatments for people and pets
Continue reading
With more people turning to their smartphones to complement their medical care, and the number of apps flooding the marketplace, how can a new consumer health app catch the attention of investors?Continue reading
First Biosimilar Avastin® and Herceptin® Products to Launch in the United StatesContinue reading
Breakthrough in Clinical Diagnostics for Medical Microbial Testing in the Dermatology and Podiatric Fungal Markets
